SunTrust Robinson Humphrey Assumes Dicerna Pharmaceuticals at Buy, Raises $24 Price Target

SunTrust Robinson Humphrey assumes Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy rating and a $24 price target.

Benzinga · 11/18/2019 14:33

SunTrust Robinson Humphrey assumes Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy rating and a $24 price target.